Tag: VRX
Valeant Pharmaceuticals (VRX) Stock: Headed Up On Upgrade
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) is having a strong start to the trading session this morning, and for good reason. The company was...
Valeant Pharmaceuticals (VRX) Stock: Headed Up On Strong Guidance!
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) is having an overwhelmingly strong start to the trading session in the pre-market hours this morning after reporting...
Valeant Pharmaceuticals (VRX) Stock: Falling Hard On Earnings And Guidance
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) is having an overwhelmingly rough start to the trading session this morning, and for good reason. The company reported...
Valeant Pharmaceuticals (VRX) Stock: Gains On Debt Repayment
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) is having an incredibly strong day in the market today, and for good reason. The company announced that...
Valeant Pharmaceuticals (VRX) Stock: Gaining On Strong Earnings
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) is having an overwhelmingly strong day in the market today, and for good reason. The company announced its...
Valeant Pharmaceuticals (VRX) Stock: Gaining On FDA Approval
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) is having an overwhelmingly strong start to the trading session this morning in the pre-market hours, and for...
Valeant Pharmaceuticals (VRX) Stock: Gaining On Earnings And Rumors
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) is having an overwhelmingly strong time in the pre-market hours, which is interesting considering that the company reported...
Valeant Pharmaceuticals (VRX) Stock: Gaining On Redemption Of Notes
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) is having a great start to the trading session this morning, and for good reason. The company announced...
Valeant Pharmaceuticals (VRX) Stock: Gaining On iNova Pharmaceuticals Sale
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company...
Mallinckrodt (MNK) Stock: Dives On Citron Sell-Side Report
Mallinckrodt PLC (NYSE: MNK) is having an overwhelmingly rough day in the market today, and for good reason. Citron research has waged an attack...
Why Gold Outperforms Bitcoin as a Crisis Hedge
2016 won't be the greatest year at the financial markets. Many experts see a global recession coming up, dark clouds on the horizon. Therefore, investors...
Reviews
TradeMiner Review: Is It Worth Your While?
There are tons of trading tools out there, but none of them are quite like TradeMiner. The software doesn’t look at your...
